Bismuth-containing quadruple therapy was recommended as a first-line treatment for Helicobacter pylori infection. This study aimed to compare real-world outcomes of various bismuth-containging quadruple regimens and identify factors influencing treatment failure. A multicenter retrospective analysis was conducted and study outcomes included eradication rates and incidence of adverse events.
Study Type
OBSERVATIONAL
Enrollment
1,730
This study is a retrospective study, and all data have been collected in advance with no active intervention required.
Qilu Hospital of Shandong University
Jinan, Shandong, China
Eradication rate
Comparison of eradication rates among quadruple therapies for Helicobacter pylori
Time frame: 6 weeks after treatment completion
Adverse events
Time frame: Immediately after treatment completion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.